Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
100%
Myeloid Differentiation Factor 88 (MyD88)
100%
Alpha-synuclein (α-syn)
33%
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
26%
C-Jun N-terminal Kinase 3
26%
Knock-in Mouse Model
20%
Neurodegeneration
20%
Disease Case
13%
Cell Damage
13%
Neurotoxin
13%
Null Mice
13%
Mitochondrial Proteins
13%
Mouse Model
13%
Mitochondria
13%
Inherited mutation
6%
Parkinsonian
6%
New Drug Targets
6%
Nigral Dopaminergic Neuron
6%
Dopaminergic Neurodegeneration
6%
Mitochondrial Physiology
6%
Dopaminergic Cell Death
6%
Transgenic
6%
Mitochondria-mediated Cell Death
6%
Substantia Nigra Pars Compacta
6%
Affected Area
6%
New Targets
6%
Disease Pathogenesis
6%
Dopamine
6%
Stress-activated Protein Kinase
6%
Disease Development
6%
Parkinson Patients
6%
Neurodegenerative Movement Disorder
6%
Mitochondrial Function
6%
Lewy Bodies
6%
Neuron-specific
6%
Cytosol
6%
Specific Aims
6%
Neuroscience
Parkinson's Disease
100%
Synuclein
33%
Kinase
26%
Tetrahydropyridine
26%
Amino Terminal Sequence
26%
Neurodegeneration
26%
Mitochondrion
20%
Cell Damage
13%
Neurotoxin
13%
Mitochondrial Protein
13%
Cell Death
13%
Dopaminergic
13%
C-Jun N-Terminal Kinases
6%
Treatment of Parkinson's Disease
6%
Transgene
6%
In Vitro
6%
Substantia Nigra Pars Compacta
6%
Lewy Body
6%
MYD88
6%
Stereotypic Movement Disorder
6%
Dopaminergic Neuron
6%
Dopamine
6%
Inherited Mutation
6%